drug resistance

• 

ICR cancer drug programme aims to deliver a step change in cancer treatment

By Sharon Kell|2019-05-16T14:29:40+00:0016 May 2019|Cancer news|

The world's first 'Darwinian' cancer drug programme was launched by [...]

Read More

Comments Off on ICR cancer drug programme aims to deliver a step change in cancer treatment

• 

Clinical significance of PD-1 and PD-L1 receptors in kidney cancer

By Sharon Kell|2019-05-01T08:52:26+00:001 May 2019|Drug treatments|

A recent study, published in Cancer Science this month, suggests [...]

Read More

Comments Off on Clinical significance of PD-1 and PD-L1 receptors in kidney cancer

• 

The hunt for a kidney cancer biomarker reveals two more potential candidates

By Sharon Kell|2019-03-27T10:17:30+00:0027 Mar 2019|Cancer news|

As the hunt for a reliable biomarker for renal cell [...]

Read More

Comments Off on The hunt for a kidney cancer biomarker reveals two more potential candidates

Scientists discover the mechanism for resistance to immunotherapy treatment

By Sharon Kell|2018-01-05T15:28:30+00:005 Jan 2018|Cancer news|

Scientists from the Dana-Farber Cancer Institute in Boston, USA, have [...]

Read More

Comments Off on Scientists discover the mechanism for resistance to immunotherapy treatment

• 

Researchers discover the mechanism that causes kidney cancer to recur

By Sharon Kell|2017-10-30T08:55:32+00:0030 Oct 2017|Cancer news|

New research published in the journal Nature Communications this month has identified [...]

Read More

Comments Off on Researchers discover the mechanism that causes kidney cancer to recur

• 

Researchers discover a mechanism that reverses TKI drug resistance

By Sharon Kell|2016-06-14T18:07:41+00:0014 Jun 2016|Drug treatments|

Researchers from the Breast Cancer Clinical Research Unit at the [...]

Read More

Comments Off on Researchers discover a mechanism that reverses TKI drug resistance